Literature DB >> 22216523

The influence of thiethylperazine on the absorption of effervescent aspirin in migraine.

G Wainscott1, T Kaspi, G N Volans.   

Abstract

The absorption of effervescent aspirin was studied in three groups of patients during attacks of migraine. The first group received intramuscular thiethylperazine 10 min before effervescent aspirin; the second group received intramuscular metoclopramide 10 min before effervescent aspirin; and the third group received effervescent aspirin alone. Where possible each patient was retested when headache-free but under conditions which were otherwise as similar as possible to those during the acute attack. Intramuscular metoclopramide corrected the impairment of drug absorption that occurred during a migraine attack, whereas thiethylperazine did not. In the group of patients treated with thiethylperazine and aspirin, the impairment of absorption did not correlate with the duration of the symptoms, nor with the severity of the headache and nausea. Patients treated with thiethylperazine and aspirin tended to take longer to recover than those patients treated with metoclopramide and aspirin. However, in the thiethylperazine treated group, the time to recover did not correlate with the salicylate level achieved.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 22216523      PMCID: PMC1428962          DOI: 10.1111/j.1365-2125.1976.tb00351.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  GASTROINTESTINAL FACTORS IN ASPIRIN ABSORPTION. A QUANTITATIVE STUDY.

Authors:  E B TRUITT; A M MORGAN
Journal:  J Pharm Sci       Date:  1964-02       Impact factor: 3.534

2.  Effect of an anticholinergic agent on riboflavin absorption in man.

Authors:  G Levy; M Gibaldi; J A Procknal
Journal:  J Pharm Sci       Date:  1972-05       Impact factor: 3.534

3.  Altered absorption of digoxin in patients given propantheline and metoclopramide.

Authors:  V Manninen; A Apajalahti; J Melin; M Karesoja
Journal:  Lancet       Date:  1973-02-24       Impact factor: 79.321

4.  The dependence of paracetamol absorption on the rate of gastric emptying.

Authors:  R C Heading; J Nimmo; L F Prescott; P Tothill
Journal:  Br J Pharmacol       Date:  1973-02       Impact factor: 8.739

5.  The influence of metoclopramide on drug absorption.

Authors:  J Nimmo
Journal:  Postgrad Med J       Date:  1973-07       Impact factor: 2.401

6.  Delayed absorption of phenylbutazone caused by desmethylimipramine in humans.

Authors:  S Consolo; P L Morselli; M Zaccala; S Garattini
Journal:  Eur J Pharmacol       Date:  1970-05       Impact factor: 4.432

7.  Absorption of antibiotics: influence of metoclopramide and atropine on serum levels of pivampicillin and tetracycline.

Authors:  G Gothoni; P Pentikäinen; H I Vapaatalo; R Hackman; K af Björksten
Journal:  Ann Clin Res       Date:  1972-08

8.  The effect of metoclopramide on the absorption of effervescent aspirin in migraine.

Authors:  G N Volans
Journal:  Br J Clin Pharmacol       Date:  1975-02       Impact factor: 4.335

9.  Pharmacological modification of gastric emptying: effects of propantheline and metoclopromide on paracetamol absorption.

Authors:  J Nimmo; R C Heading; P Tothill; L F Prescott
Journal:  Br Med J       Date:  1973-03-10

10.  Absorption of effervescent aspirin during migraine.

Authors:  G N Volans
Journal:  Br Med J       Date:  1974-11-02
View more
  3 in total

Review 1.  Pharmacological Agents Affecting Emesis : A Review (Part II).

Authors:  F Mitchelson
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

Review 2.  Migraine and drug absorption.

Authors:  G N Volans
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

Review 3.  Metoclopramide. An updated review of its pharmacological properties and clinical use.

Authors:  R A Harrington; C W Hamilton; R N Brogden; J A Linkewich; J A Romankiewicz; R C Heel
Journal:  Drugs       Date:  1983-05       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.